Lung transplantation and systemic sclerosis.

V. Rosas, John Conte, S. C. Yang, S. P. Gaine, M. Borja, F. M. Wigley, B. White, J. B. Orens

Research output: Contribution to journalReview articlepeer-review

85 Scopus citations

Abstract

We performed lung transplantation in nine patients with Scleroderma related lung disease. Patient characteristics included: 7 (78%) females, 6 (67%) with limited and 3 (33%) with diffuse Scleroderma. Pulmonary fibrosis was present in 7 (78%) and pulmonary hypertension in 4 (44%). All patients were carefully screened by the Johns Hopkins and University of Maryland Scleroderma Center and only referred for transplantation when concomitant renal insufficiency (creatinine clearance < or = 50 ml/min), aspiration, and skin brakdown were excluded. When compared to a similar group of transplant patients with nonscleroderma lung disease (primary pulmonary fibrosis), there was no significant difference in post-transplant survival at four years (76.2 +/- 0.15% vs. 69.2% +/- 0.12%), mean annual incidence rate for acute rejection (0.14 +/- 0.14 vs. 0.47 +/- 0.13) and infection (viral 0.17 +/- 0.17 vs. 0.29 +/- 0.11) (bacterial 0.17 +/- 0.17 vs. 1.4 +/- 0.4) (fungal 0.99 +/- 0.69 vs. 0.36 +/- 0.16) or serum creatinine (1.55 +/- 0.34 mg/dl vs. 1.15 +/- 0.09 mg/dl). We conclude that lung transplantation is viable option for carefully selected patients with scleroderma related lung disease.

Original languageEnglish (US)
Pages (from-to)38-43
Number of pages6
JournalAnnals of transplantation : quarterly of the Polish Transplantation Society
Volume5
Issue number3
StatePublished - 2000

All Science Journal Classification (ASJC) codes

  • Transplantation

Fingerprint

Dive into the research topics of 'Lung transplantation and systemic sclerosis.'. Together they form a unique fingerprint.

Cite this